Stephen E. Pautler, MD
University of Western Ontario
My originally funded project, “Does Ochratoxin A Exposure Lead to Upper Tract Transitional Cell Carcinoma, Renal Cell Carcinoma or Germ Cell Malignancy?” is still ongoing. Thus far we have developed an IHC method for detecting OTA in both benign and malignant tissues. We are currently validating this technique. Additionally, we will be testing a series of tumor bank specimens from patients in Ontario.
The Young Investigators grant provided funding to investigate the role of OTA in urologic malignanies. This aided in my development as a urologic oncologist.